{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T20:07:02Z","timestamp":1794341222002,"version":"4.9.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"DOI":"10.1186\/s12887-026-06539-6","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T04:23:16Z","timestamp":1770697396000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Levetiracetam versus phenobarbital as first-line therapy for neonatal seizures: a comprehensive systematic review and meta-analysis with meta-regression of 26 studies involving 9,854 neonates"],"prefix":"10.1186","volume":"26","author":[{"given":"Mostafa Hossam El Din","family":"Moawad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelrahman M.","family":"Elettreby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibraheem M.","family":"Alkhawaldeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamza A.","family":"Abdul-Hafez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Mohammad Asar Mohammad","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar Mohamed","family":"Helal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Karawya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdallah","family":"AlHusan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malik","family":"Allahham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youcef","family":"Chair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadeel Amin Al","family":"Kabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Serag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Abouzid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,10]]},"reference":[{"key":"6539_CR1","doi-asserted-by":"publisher","unstructured":"Glass HC, Pham TN, Danielsen B, Towner D, Glidden D, Wu YW. Antenatal and intrapartum risk factors for seizures in term newborns: a population-based study, California 1998\u20132002, (in eng). J Pediatr. 2009;154(1):24\u20138. https:\/\/doi.org\/10.1016\/j.jpeds.2008.07.008.","DOI":"10.1016\/j.jpeds.2008.07.008"},{"key":"6539_CR2","doi-asserted-by":"publisher","unstructured":"B\u00e4ttig L et al. Levetiracetam versus Phenobarbital for Neonatal Seizures: A Retrospective Cohort Study, (in eng), Pediatr Neurol. 2023;138:62\u201370.\u00a0https:\/\/doi.org\/10.1016\/j.pediatrneurol.2022.10.004.","DOI":"10.1016\/j.pediatrneurol.2022.10.004"},{"key":"6539_CR3","doi-asserted-by":"publisher","unstructured":"Kohelet D, Shochat R, Lusky A, Reichman B. Risk factors for neonatal seizures in very low birthweight infants: population-based survey, (in eng). J Child Neurol. 2004;19(2):123\u20138. https:\/\/doi.org\/10.1177\/08830738040190020701.","DOI":"10.1177\/08830738040190020701"},{"key":"6539_CR4","doi-asserted-by":"publisher","unstructured":"Ramantani G et al. Neonatal Seizures-Are We there Yet? (in eng) Neuropediatrics.\u00a02019;50(5):280\u2013293.\u00a0https:\/\/doi.org\/10.1055\/s-0039-1693149.","DOI":"10.1055\/s-0039-1693149"},{"key":"6539_CR5","doi-asserted-by":"publisher","unstructured":"Pisani F, Spagnoli C, Falsaperla R, Nagarajan L, Ramantani G. Seizures in the neonate: A review of etiologies and outcomes, (in eng). Seizure. 2021;85:48-56.\u00a0https:\/\/doi.org\/10.1016\/j.seizure.2020.12.023.","DOI":"10.1016\/j.seizure.2020.12.023"},{"key":"6539_CR6","doi-asserted-by":"publisher","unstructured":"Pressler RM, Mangum B. Newly emerging therapies for neonatal seizures, (in eng). Semin Fetal Neonatal Med. 2013;18(4):216\u201323. https:\/\/doi.org\/10.1016\/j.siny.2013.04.005.","DOI":"10.1016\/j.siny.2013.04.005"},{"key":"6539_CR7","doi-asserted-by":"publisher","unstructured":"Glass HC, Kan J, Bonifacio SL, Ferriero DM. Neonatal seizures: treatment practices among term and preterm infants, (in eng). Pediatr Neurol. 2012;46(2):111-5.\u00a0https:\/\/doi.org\/10.1016\/j.pediatrneurol.2011.11.006.","DOI":"10.1016\/j.pediatrneurol.2011.11.006"},{"key":"6539_CR8","doi-asserted-by":"publisher","unstructured":"Painter MJ, et al. Phenobarbital compared with phenytoin for the treatment of neonatal seizures, (in eng). N Engl J Med. Aug 12 1999;341(7):485\u20139. https:\/\/doi.org\/10.1056\/nejm199908123410704.","DOI":"10.1056\/nejm199908123410704"},{"key":"6539_CR9","doi-asserted-by":"publisher","unstructured":"Scher MS, Alvin J, Gaus L, Minnigh B, Painter MJ. Uncoupling of EEG-clinical neonatal seizures after antiepileptic drug use, (in eng). Pediatr Neurol. 2003;28(4):277\u201380.\u00a0https:\/\/doi.org\/10.1016\/s0887-8994(02)00621-5.","DOI":"10.1016\/s0887-8994(02)00621-5"},{"issue":"23","key":"6539_CR10","doi-asserted-by":"publisher","first-page":"15089","DOI":"10.1073\/pnas.222550499","volume":"99","author":"P Bittigau","year":"2002","unstructured":"Bittigau P, et al. Antiepileptic drugs and apoptotic neurodegeneration in the developing brain. Proc Natl Acad Sci U S A. 2002;99(23):15089\u201394. https:\/\/doi.org\/10.1073\/pnas.222550499.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"6539_CR11","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/ana.23600","volume":"72","author":"PA Forcelli","year":"2012","unstructured":"Forcelli PA, Janssen MJ, Vicini S, Gale K. Neonatal exposure to antiepileptic drugs disrupts striatal synaptic development. Ann Neurol. 2012;72(3):363\u201372. https:\/\/doi.org\/10.1002\/ana.23600.","journal-title":"Ann Neurol"},{"issue":"2","key":"6539_CR12","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.expneurol.2005.01.006","volume":"193","author":"D Manthey","year":"2005","unstructured":"Manthey D, et al. Sulthiame but not levetiracetam exerts neurotoxic effect in the developing rat brain. Exp Neurol. 2005;193(2):497\u2013503. https:\/\/doi.org\/10.1016\/j.expneurol.2005.01.006.","journal-title":"Exp Neurol"},{"issue":"2\u20133","key":"6539_CR13","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/s0014-2999(98)00410-5","volume":"353","author":"H Klitgaard","year":"1998","unstructured":"Klitgaard H, Matagne A, Gobert J, W\u00fclfert E. Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy. Eur J Pharmacol. 1998;353(2\u20133):191\u2013206. https:\/\/doi.org\/10.1016\/s0014-2999(98)00410-5.","journal-title":"Eur J Pharmacol"},{"key":"6539_CR14","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.brainres.2014.01.034","volume":"1556","author":"E Griesmaier","year":"2014","unstructured":"Griesmaier E, et al. Levetiracetam increases neonatal hypoxic-ischemic brain injury under normothermic, but not hypothermic conditions. Brain Res. 2014;1556:10\u20138. https:\/\/doi.org\/10.1016\/j.brainres.2014.01.034.","journal-title":"Brain Res"},{"key":"6539_CR15","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.brainres.2016.05.040","volume":"1646","author":"K Strasser","year":"2016","unstructured":"Strasser K, et al. Dose-dependent effects of levetiracetam after hypoxia and hypothermia in the neonatal mouse brain. Brain Res. 2016;1646:116\u201324. https:\/\/doi.org\/10.1016\/j.brainres.2016.05.040.","journal-title":"Brain Res"},{"issue":"1","key":"6539_CR16","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1055\/s-0037-1608653","volume":"49","author":"DC McHugh","year":"2018","unstructured":"McHugh DC, Lancaster S, Manganas LN. A systematic review of the efficacy of levetiracetam in neonatal seizures. Neuropediatrics. 2018;49(1):12\u20137. https:\/\/doi.org\/10.1055\/s-0037-1608653.","journal-title":"Neuropediatrics"},{"issue":"20","key":"6539_CR17","doi-asserted-by":"publisher","first-page":"3923","DOI":"10.1080\/14767058.2020.1844651","volume":"35","author":"D Sharma","year":"2022","unstructured":"Sharma D, Hussain AM, Sharma SS. Efficacy of levetiracetam in neonatal seizures: a systematic review. J Matern Fetal Neonatal Med. 2022;35(20):3923\u201330. https:\/\/doi.org\/10.1080\/14767058.2020.1844651.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"3","key":"6539_CR18","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1136\/archdischild-2020-320311","volume":"106","author":"S Giva","year":"2021","unstructured":"Giva S, Boyle MA, Gorman KM. Should levetiracetam rather than phenobarbitone be the first-line treatment for neonatal seizures? Arch Dis Child. 2021;106(3):301\u20133.","journal-title":"Arch Dis Child"},{"key":"6539_CR19","doi-asserted-by":"publisher","unstructured":"Page MJ et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews, (in eng). BMJ.\u00a02021;372:n71.\u00a0https:\/\/doi.org\/10.1136\/bmj.n71.","DOI":"10.1136\/bmj.n71"},{"key":"6539_CR20","doi-asserted-by":"crossref","unstructured":"Cumpston M et al. Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database Syst Rev.\u00a02019;2019(10):ED000142.","DOI":"10.1002\/14651858.ED000142"},{"issue":"5","key":"6539_CR21","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2022-058114","volume":"150","author":"EM Mizrahi","year":"2022","unstructured":"Mizrahi EM, Pressler RM, C. o. C. Task Force on Neonatal Seizures, I. L. A. E. Terminology. The international league against epilepsy new classification of neonatal seizures. Pediatrics. 2022;150(5):e2022058114.","journal-title":"Pediatrics"},{"key":"6539_CR22","doi-asserted-by":"publisher","unstructured":"Sterne JAC et al. RoB 2: a revised tool for assessing risk of bias in randomised trials, (in eng). BMJ.\u00a02019;366:l4898.\u00a0https:\/\/doi.org\/10.1136\/bmj.l4898.","DOI":"10.1136\/bmj.l4898"},{"issue":"9","key":"6539_CR23","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603\u20135. https:\/\/doi.org\/10.1007\/s10654-010-9491-z.","journal-title":"Eur J Epidemiol"},{"issue":"7","key":"6539_CR24","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.jclinepi.2014.01.006","volume":"67","author":"G Gopalakrishna","year":"2014","unstructured":"Gopalakrishna G, et al. Applying grading of recommendations assessment, development and evaluation (GRADE) to diagnostic tests was challenging but doable. J Clin Epidemiol. 2014;67(7):760\u20138.","journal-title":"J Clin Epidemiol"},{"key":"6539_CR25","first-page":"7","volume":"31","author":"J Ghaffar","year":"2020","unstructured":"Ghaffar J, Riaz A, Uzair AOV, Bhatti A. Comparative efficacy of intravenous levetiracetam vs phenobarbitone in neonatal seizures. Med Forum Mon. 2020;31:7.","journal-title":"Med Forum Mon"},{"issue":"2","key":"6539_CR26","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3329\/jdmc.v27i2.45831","volume":"27","author":"MTH Khan","year":"2018","unstructured":"M. Khan, M. Rahman, M. Banerjee, M. Uddin, N. Nahar, and M. Akhter, \"Comparative Efficacy of Phenobarbitone versus levetiracetam in the initial treatment of neonatal seizure,\" J of Dhaka Med Coll. 2020;27:182\u20139. https:\/\/doi.org\/10.3329\/jdmc.v27i2.45831.","journal-title":"J Dhaka Med Coll"},{"issue":"6","key":"6539_CR27","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.18203\/2320-6012.ijrms20161763","volume":"4","author":"S Perveen","year":"2016","unstructured":"Perveen S, Singh A, Upadhyay A, Singh N, Chauhan R. A randomized controlled trial on comparison of phenobarbitone and levetiracetam for the treatment of neonatal seizures: pilot study. Int J Res Med Sci. 2016;4(6):2073\u20138.","journal-title":"Int J Res Med Sci"},{"issue":"2","key":"6539_CR28","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3329\/bjch.v42i2.37761","volume":"42","author":"AFM Pervez","year":"2018","unstructured":"Pervez AFM, et al. Randomized controlled trial between levetiracetam and phenobarbital in the treatment of neonatal seizure due to perinatal asphyxia. Bangladesh J Child Health. 2018;42(2):67\u201372.","journal-title":"Bangladesh J Child Health"},{"issue":"11","key":"6539_CR29","doi-asserted-by":"publisher","first-page":"605","DOI":"10.32677\/IJCH.2019.v06.i11.008","volume":"6","author":"A Prakash","year":"2019","unstructured":"Prakash A, Richa R, Sahni GS. Neonatal seizures\u2013levetiracetam versus phenobarbital. Indian J Child Health. 2019;6(11):605\u20138.","journal-title":"Indian J Child Health"},{"issue":"4","key":"6539_CR30","first-page":"1003","volume":"74","author":"MK Surani","year":"2024","unstructured":"Surani MK, Malik AR, Fatima N, Roomi MA, Arshad A, Nadeem A. Comparison of levetiracetam and phenobarbital for treating neonatal seizures associated with hypoxic-ischemic encephalopathy. Pak Armed Forces Med J. 2024;74(4):1003.","journal-title":"Pak Armed Forces Med J"},{"key":"6539_CR31","doi-asserted-by":"publisher","unstructured":"R. K. Jain and H. Kumar, \u201cPhenobarbitone versus levetiracetam in neonatal seizures\u201d, Int J Contemp Pediatr.\u00a02020:7(8):1701\u20134. https:\/\/doi.org\/10.18203\/2349-3291.ijcp20203051.","DOI":"10.18203\/2349-3291.ijcp20203051"},{"issue":"8","key":"6539_CR32","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s13312-019-1586-3","volume":"56","author":"VK Gowda","year":"2019","unstructured":"Gowda VK, Romana A, Shivanna NH, Benakappa N, Benakappa A. Levetiracetam versus phenobarbitone in neonatal seizures\u2014a randomized controlled trial. Indian Pediatr. 2019;56(8):643\u20136.","journal-title":"Indian Pediatr"},{"key":"6539_CR33","unstructured":"Gupta SDas G, Singh D, Gupta S, Prajapati J. Comparative study of phenobarbitone and Levetiracetam as first line anticonvulsant in neonatal seizures treatment. International Journal of Life Sciences Biotechnology and Pharma Research. 2023;12(2):2250-3137. https:\/\/www.ijlbpr.com\/uploadfiles\/116vol12issue2pp646-650.20230420060038.pdf"},{"key":"6539_CR34","doi-asserted-by":"publisher","DOI":"10.1177\/2333794x221143572","volume":"9","author":"NE Akeel","year":"2022","unstructured":"Akeel NE, et al. A comparative study of Levetiracetam and Phenobarbital for Neonatal Seizures as a first line treatment. Glob Pediatr Health. 2022;9:2333794X221143572. https:\/\/doi.org\/10.1177\/2333794x221143572.","journal-title":"Glob Pediatr Health"},{"issue":"3","key":"6539_CR35","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1111\/epi.14671","volume":"60","author":"HC Glass","year":"2019","unstructured":"Glass HC, et al. Response to antiseizure medications in neonates with acute symptomatic seizures. Epilepsia. 2019;60(3):e20\u20134. https:\/\/doi.org\/10.1111\/epi.14671.","journal-title":"Epilepsia"},{"issue":"5","key":"6539_CR36","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1007\/s00431-023-04864-x","volume":"182","author":"G Gyandeep","year":"2023","unstructured":"Gyandeep G, Behura SS, Sahu SK, Panda SK. Comparison between phenobarbitone and levetiracetam as the initial anticonvulsant in preterm neonatal seizures - a pilot randomized control trial in developing country setup. Eur J Pediatr. 2023;182(5):2133\u20138. https:\/\/doi.org\/10.1007\/s00431-023-04864-x.","journal-title":"Eur J Pediatr"},{"issue":"2","key":"6539_CR37","doi-asserted-by":"publisher","first-page":"65","DOI":"10.22037\/ijcn.v19i2.45234","volume":"19","author":"N Khosroshahi","year":"2025","unstructured":"Khosroshahi N, Kamrani K, Moradi M, Sadeghirad P, Khabazi Oskouie A. Comparing the effectiveness and safety of intravenous levetiracetam and phenobarbital as first-line therapies for neonatal seizures: a randomized clinical trial. Iran J Child Neurol. 2025;19(2):65\u201375. https:\/\/doi.org\/10.22037\/ijcn.v19i2.45234.","journal-title":"Iran J Child Neurol"},{"issue":"4","key":"6539_CR38","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1080\/00207454.2019.1687469","volume":"130","author":"BK Liu","year":"2020","unstructured":"Liu BK, Jiang L, Li XJ, Hong SQ, Chen W, Hu Y. Efficacy and safety of levetiracetam in the off-label treatment of neonatal seizures. Int J Neurosci. 2020;130(4):336\u201342. https:\/\/doi.org\/10.1080\/00207454.2019.1687469.","journal-title":"Int J Neurosci"},{"issue":"5","key":"6539_CR39","doi-asserted-by":"publisher","first-page":"482","DOI":"10.5863\/1551-6776-29.5.482","volume":"29","author":"D Long","year":"2024","unstructured":"Long D, Sutton C, Hale J. Efficacy of Levetiracetam vs Phenobarbital as First Line Therapy for the Treatment of Neonatal Seizures. J Pediatr Pharmacol Ther. 2024;29(5):482\u20136. https:\/\/doi.org\/10.5863\/1551-6776-29.5.482.","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"11","key":"6539_CR40","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/jp.2013.116","volume":"33","author":"NL Maitre","year":"2013","unstructured":"Maitre NL, Smolinsky C, Slaughter JC, Stark AR. Adverse neurodevelopmental outcomes after exposure to phenobarbital and levetiracetam for the treatment of neonatal seizures. J Perinatol. 2013;33(11):841\u20136. https:\/\/doi.org\/10.1038\/jp.2013.116.","journal-title":"J Perinatol"},{"key":"6539_CR41","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.yebeh.2018.09.015","volume":"88","author":"LM Rao","year":"2018","unstructured":"Rao LM, et al. A comparison of levetiracetam and phenobarbital for the treatment of neonatal seizures associated with hypoxic-ischemic encephalopathy. Epilepsy Behav. 2018;88:212\u20137. https:\/\/doi.org\/10.1016\/j.yebeh.2018.09.015.","journal-title":"Epilepsy Behav"},{"issue":"3","key":"6539_CR42","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41372-021-01240-1","volume":"42","author":"EK Sewell","year":"2022","unstructured":"Sewell EK, Hamrick SEG, Patel RM, Bennett M, Tolia VN, Ahmad KA. Association between anti-seizure medication and outcomes in infants. J Perinatol. 2022;42(3):359\u201364. https:\/\/doi.org\/10.1038\/s41372-021-01240-1.","journal-title":"J Perinatol"},{"key":"6539_CR43","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2019-3182","author":"C Sharpe","year":"2020","unstructured":"Sharpe C, et al. Levetiracetam versus phenobarbital for neonatal seizures: a randomized controlled trial. Pediatrics. 2020. https:\/\/doi.org\/10.1542\/peds.2019-3182.","journal-title":"Pediatrics"},{"issue":"7","key":"6539_CR44","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1542\/hpeds.2021-006415","volume":"12","author":"S Susnerwala","year":"2022","unstructured":"Susnerwala S, Joshi A, Deshmukh L, Londhe A. Levetiracetam or phenobarbitone as a first-line anticonvulsant in asphyxiated term newborns? An open-label, single-center, randomized, controlled, pragmatic trial. Hosp Pediatr. 2022;12(7):647\u201353. https:\/\/doi.org\/10.1542\/hpeds.2021-006415.","journal-title":"Hosp Pediatr"},{"issue":"4","key":"6539_CR45","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1111\/epi.16469","volume":"61","author":"C Thibault","year":"2020","unstructured":"Thibault C, et al. A retrospective comparison of phenobarbital and levetiracetam for the treatment of seizures following cardiac surgery in neonates. Epilepsia. 2020;61(4):627\u201335. https:\/\/doi.org\/10.1111\/epi.16469.","journal-title":"Epilepsia"},{"issue":"2","key":"6539_CR46","doi-asserted-by":"publisher","first-page":"574","DOI":"10.4103\/0028-3886.344647","volume":"70","author":"RB Thomas","year":"2022","unstructured":"Thomas RB, Muttavarapu SS, Shetty PK, Lewis LE. Efficacy and utilization patterns of anti-epileptic drugs in the management of neonatal seizures: a comparative exploration. Neurol India. 2022;70(2):574\u20138. https:\/\/doi.org\/10.4103\/0028-3886.344647.","journal-title":"Neurol India"},{"key":"6539_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare12070800","author":"HH Toptan","year":"2024","unstructured":"Toptan HH, et al. Comparative outcomes of levetiracetam and phenobarbital usage in the treatment of neonatal seizures: a retrospective analysis. Healthcare. 2024. https:\/\/doi.org\/10.3390\/healthcare12070800.","journal-title":"Healthcare"},{"issue":"5","key":"6539_CR48","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1177\/08830738221086107","volume":"37","author":"C Verwoerd","year":"2022","unstructured":"Verwoerd C, Limjoco J, Rajamanickam V, Knox A. Efficacy of levetiracetam and phenobarbital as first-line treatment for neonatal seizures. J Child Neurol. 2022;37(5):401\u20139. https:\/\/doi.org\/10.1177\/08830738221086107.","journal-title":"J Child Neurol"},{"issue":"2","key":"6539_CR49","doi-asserted-by":"publisher","first-page":"144","DOI":"10.5863\/1551-6776-26.2.144","volume":"26","author":"CB Wagner","year":"2021","unstructured":"Wagner CB, et al. Levetiracetam compared to phenobarbital as a first line therapy for neonatal seizures: an unexpected influence of benzodiazepines on seizure response. J Pediatr Pharmacol Ther. 2021;26(2):144\u201350. https:\/\/doi.org\/10.5863\/1551-6776-26.2.144.","journal-title":"J Pediatr Pharmacol Ther"},{"key":"6539_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.747745","volume":"12","author":"MY Qiao","year":"2021","unstructured":"Qiao MY, Cui HT, Zhao LZ, Miao JK, Chen QX. Efficacy and safety of levetiracetam vs. phenobarbital for neonatal seizures: a systematic review and meta-analysis. Front Neurol. 2021;12:747745. https:\/\/doi.org\/10.3389\/fneur.2021.747745.","journal-title":"Front Neurol"},{"issue":"1","key":"6539_CR51","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s12098-023-04905-1","volume":"92","author":"J Kumar","year":"2025","unstructured":"Kumar J, Yadav B, Meena J, Yadav J, Sahu JK. Levetiracetam versus phenobarbitone for management of neonatal seizures: a systematic review and meta-analysis. Indian J Pediatr. 2025;92(1):29\u201341. https:\/\/doi.org\/10.1007\/s12098-023-04905-1.","journal-title":"Indian J Pediatr"},{"issue":"7","key":"6539_CR52","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1093\/oxfordjournals.aje.a010079","volume":"150","author":"RM Saliba","year":"1999","unstructured":"Saliba RM, Annegers JF, Waller DK, Tyson JE, Mizrahi EM. Incidence of neonatal seizures in Harris County, Texas, 1992\u20131994. Am J Epidemiol. 1999;150(7):763\u20139. https:\/\/doi.org\/10.1093\/oxfordjournals.aje.a010079.","journal-title":"Am J Epidemiol"},{"issue":"4","key":"6539_CR53","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.siny.2013.01.001","volume":"18","author":"LG van Rooij","year":"2013","unstructured":"van Rooij LG, Hellstr\u00f6m-Westas L, de Vries LS. Treatment of neonatal seizures. Semin Fetal Neonatal Med. 2013;18(4):209\u201315. https:\/\/doi.org\/10.1016\/j.siny.2013.01.001.","journal-title":"Semin Fetal Neonatal Med"},{"issue":"5","key":"6539_CR54","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.siny.2017.07.008","volume":"22","author":"M El-Dib","year":"2017","unstructured":"El-Dib M, Soul JS. The use of phenobarbital and other anti-seizure drugs in newborns. Semin Fetal Neonatal Med. 2017;22(5):321\u20137. https:\/\/doi.org\/10.1016\/j.siny.2017.07.008.","journal-title":"Semin Fetal Neonatal Med"},{"issue":"2","key":"6539_CR55","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/ana.25959","volume":"89","author":"JS Soul","year":"2021","unstructured":"Soul JS, et al. A pilot randomized, controlled, double-blind trial of bumetanide to treat neonatal seizures. Ann Neurol. 2021;89(2):327\u201340. https:\/\/doi.org\/10.1002\/ana.25959.","journal-title":"Ann Neurol"},{"key":"6539_CR56","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/3683548","volume":"2019","author":"R Falsaperla","year":"2019","unstructured":"Falsaperla R, et al. Short-term neurodevelopmental outcome in term neonates treated with phenobarbital versus levetiracetam: a single-center experience. Behav Neurol. 2019;2019:3683548. https:\/\/doi.org\/10.1155\/2019\/3683548.","journal-title":"Behav Neurol"},{"issue":"5","key":"6539_CR57","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1528-1167.2007.01285.x","volume":"48","author":"JS Kim","year":"2007","unstructured":"Kim JS, Kondratyev A, Tomita Y, Gale K. Neurodevelopmental impact of antiepileptic drugs and seizures in the immature brain. Epilepsia. 2007;48(5):19\u201326. https:\/\/doi.org\/10.1111\/j.1528-1167.2007.01285.x.","journal-title":"Epilepsia"},{"key":"6539_CR58","doi-asserted-by":"publisher","unstructured":"Shankaran S, et al. Neurodevelopmental outcome of premature infants after antenatal phenobarbital exposure, (in eng). Am J Obstet Gynecol. Jul 2002;187(1):171\u20137. https:\/\/doi.org\/10.1067\/mob.2002.122445.","DOI":"10.1067\/mob.2002.122445"},{"key":"6539_CR59","doi-asserted-by":"publisher","unstructured":"Shankaran S et al. The effect of antenatal phenobarbital therapy on neonatal intracranial hemorrhage in preterm infants, (in eng), N Engl J Med, vol. 337, no. 7, pp. 466\u2009\u2013\u200971, Aug 14 1997, https:\/\/doi.org\/10.1056\/nejm199708143370705","DOI":"10.1056\/nejm199708143370705"},{"key":"6539_CR60","doi-asserted-by":"publisher","unstructured":"Ries M. Cognitive effects of older anticonvulsants in children with epilepsy: a review and critique of the literature, (in eng), J Pediatr Pharmacol Ther, vol. 8, no. 2, pp. 115\u2009\u2013\u200931, Apr 2003, https:\/\/doi.org\/10.5863\/1551-6776-8.2.115","DOI":"10.5863\/1551-6776-8.2.115"},{"key":"6539_CR61","doi-asserted-by":"publisher","unstructured":"Kilicdag H et al. The effect of levetiracetam on neuronal apoptosis in neonatal rat model of hypoxic ischemic brain injury, (in eng), Early Hum Dev, vol. 89, no. 5, pp. 355\u2009\u2013\u200960, May 2013, https:\/\/doi.org\/10.1016\/j.earlhumdev.2012.12.002","DOI":"10.1016\/j.earlhumdev.2012.12.002"},{"key":"6539_CR62","doi-asserted-by":"publisher","unstructured":"Stienen MN et al. Anti-inflammatory effects of the anticonvulsant drug levetiracetam on electrophysiological properties of astroglia are mediated via TGF\u03b21 regulation, (in eng), Br J Pharmacol, vol. 162, no. 2, pp. 491\u2013507, Jan 2011, https:\/\/doi.org\/10.1111\/j.1476-5381.2010.01038.x","DOI":"10.1111\/j.1476-5381.2010.01038.x"},{"key":"6539_CR63","doi-asserted-by":"publisher","unstructured":"Talos DM et al. Antiepileptic effects of levetiracetam in a rodent neonatal seizure model, (in eng), Pediatr Res, vol. 73, no. 1, pp. 24\u201330, Jan 2013, https:\/\/doi.org\/10.1038\/pr.2012.151","DOI":"10.1038\/pr.2012.151"},{"key":"6539_CR64","doi-asserted-by":"publisher","unstructured":"Shallcross R, Bromley RL, Irwin B, Bonnett LJ, Morrow J, Baker GA. Child development following in utero exposure: levetiracetam vs sodium valproate, (in eng), Neurology, vol. 76, no. 4, pp. 383-9, Jan 25 2011, https:\/\/doi.org\/10.1212\/WNL.0b013e3182088297","DOI":"10.1212\/WNL.0b013e3182088297"},{"key":"6539_CR65","doi-asserted-by":"publisher","unstructured":"Tulloch JK, Carr RR, Ensom MH. A systematic review of the pharmacokinetics of antiepileptic drugs in neonates with refractory seizures, (in eng). J Pediatr Pharmacol Ther. Jan 2012;17(1):31\u201344. https:\/\/doi.org\/10.5863\/1551-6776-17.1.31.","DOI":"10.5863\/1551-6776-17.1.31"},{"key":"6539_CR66","doi-asserted-by":"publisher","unstructured":"Merhar SL, et al. Pharmacokinetics of levetiracetam in neonates with seizures, (in eng). J Pediatr. Jul 2011;159(1):152\u20134. https:\/\/doi.org\/10.1016\/j.jpeds.2011.03.057. .e3.","DOI":"10.1016\/j.jpeds.2011.03.057"},{"key":"6539_CR67","doi-asserted-by":"publisher","first-page":"295","DOI":"10.2147\/ndt.S30224","volume":"9","author":"J Cormier","year":"2013","unstructured":"Cormier J, Chu CJ. Safety and efficacy of levetiracetam for the treatment of partial onset seizures in children from one month of age. Neuropsychiatr Dis Treat. 2013;9:295\u2013306. https:\/\/doi.org\/10.2147\/ndt.S30224.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"4","key":"6539_CR68","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.pediatrneurol.2010.11.005","volume":"44","author":"O Khan","year":"2011","unstructured":"Khan O, Chang E, Cipriani C, Wright C, Crisp E, Kirmani B. Use of intravenous levetiracetam for management of acute seizures in neonates. Pediatr Neurol. 2011;44(4):265\u20139. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2010.11.005.","journal-title":"Pediatr Neurol"},{"issue":"8","key":"6539_CR69","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1007\/s00381-013-2094-8","volume":"29","author":"O Oztekin","year":"2013","unstructured":"Oztekin O, Kalay S, Tezel G, Akcakus M, Oygur N. Can we safely administer the recommended dose of phenobarbital in very low birth weight infants? Childs Nerv Syst. 2013;29(8):1353\u20137. https:\/\/doi.org\/10.1007\/s00381-013-2094-8.","journal-title":"Childs Nerv Syst"},{"issue":"2","key":"6539_CR70","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/s0928-0987(00)00145-7","volume":"12","author":"DJ Touw","year":"2000","unstructured":"Touw DJ, Graafland O, Cranendonk A, Vermeulen RJ, van Weissenbruch MM. Clinical pharmacokinetics of phenobarbital in neonates. Eur J Pharm Sci. 2000;12(2):111\u20136. https:\/\/doi.org\/10.1016\/s0928-0987(00)00145-7.","journal-title":"Eur J Pharm Sci"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-026-06539-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-026-06539-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-026-06539-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T11:42:12Z","timestamp":1773661332000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12887-026-06539-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,10]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6539"],"URL":"https:\/\/doi.org\/10.1186\/s12887-026-06539-6","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,10]]},"assertion":[{"value":"12 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"222"}}